COVID-19 vaccine access and attitudes among people experiencing homelessness from pilot mobile phone survey in Los Angeles, CA

Randall Kuhn; Benjamin Henwood; Alexander Lawton; Mary Kleva; Karthik Murali; Coley King; Lillian Gelberg

doi:10.1101/2021.03.23.21254146

Abstract

Background People experiencing homelessness (PEH) are at high risk for COVID-19 complications and fatality, and have been prioritized for vaccination in many areas. Yet little is known about vaccine acceptance in this population. The objective of this study was to determine the level of vaccine hesitancy among PEH in Los Angeles, CA and to understand the covariates of hesitancy in relation to COVID-19 risk, threat perception, self-protection and information sources.

Methods and findings A novel mobile survey platform was deployed to recruit PEH from a federally qualified health center (FQHC) in Los Angeles to participate in a monthly rapid response study of COVID-19 attitudes, behaviors, and risks. Of 90 PEH surveyed, 43 (48%) expressed some level of vaccine hesitancy based either on actual vaccine offers (17/90 = 19%) or a hypothetical offer (73/90 = 81%). In bivariate analysis, those with high COVID-19 threat perception were less likely to be vaccine hesitant (OR=0.34, P=.03), while those who frequently practiced COVID-19 protective behaviors were more likely to be vaccine hesitant (OR=2.21, P=.08). In a multivariate model, those with high threat perception (OR=0.25, P=.02) were less likely to be hesitant, while those engaging in COVID-19 protective behaviors were more hesitant (OR=3.63, P=.02). Those who trusted official sources were less hesitant (OR=0.37, P=.08) while those who trusted friends and family for COVID-19 information (OR=2.70, P=.07) were more likely to be hesitant.

Conclusions Findings suggest that targeted educational and social influence interventions are needed to address high levels of vaccine hesitancy among PEH.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Funding for this study was provided to author RK by the University of California Office of the President Emergency COVID-19 Research Seed Funding Grant #R00RG2888 (https://uckeepresearching.org/rgpo/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by the UCLA South General IRB, protocol #20-001206. Written consent was provided through electronic signature.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Our team is currently working to generate a project website where it will be possible to visualize the data from the study. This will include the ability to replicate all univariate and bivariate analyses included in this paper, with the ability to manipulate key analysis assumptions. Due to the small size of the study population, the small and geographically focused pool from which the respondents were drawn, and the sensitive nature of the data, release of the full data set would constitute an unreasonable risk of deductive disclosure and breach of confidentiality.